Delaware federal judge reverses jury verdict in CareDx’s favour | Natera’s patents covering organ transplant testing ...

The company’s nine-country ban against a Chinese rival saw the court adopt a broad interpretation of means-plus-function ...

In Wuhan Healthgen Biotech v ITC, the Federal Circuit affirmed the US International Trade Commission’s (ITC) conclusion that ...

British pharma giant says that a Federal Circuit decision could stifle competition by lowering the bar for proving patent ...

Market leader settles patent disputes with generic drug makers, blocking the release of versions of two key products | More than 80% of HIV patients in the US use Gilead’s treatments.